Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H15N3O.ClH |
| Molecular Weight | 229.707 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CO\N=C(/C#N)[C@H]1CN2CCC1CC2
InChI
InChIKey=INJWRVWKJFJRFO-SCRZZQONSA-N
InChI=1S/C10H15N3O.ClH/c1-14-12-10(6-11)9-7-13-4-2-8(9)3-5-13;/h8-9H,2-5,7H2,1H3;1H/b12-10+;/t9-;/m0./s1
Sabcomeline (SB-202026) is a potent and functionally selective M1 receptor partial agonist that originally was developed by GlaxoSmithKline. Sabcomeline had been in phase III clinical trials for the treatment of Alzheimer's disease and phase II for schizophrenia and major depressive disorder. In addition, it was studied for patients with Type 2 diabetes mellitus. However, due to poor results, the development of this drug was discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Low-affinity M(2) receptor binding state mediates mouse atrial bradycardia: comparative effects of carbamylcholine and the M(1) receptor agonists sabcomeline and xanomeline. | 2001-03 |
|
| Sabcomeline (SB-202026), a functionally selective M1 receptor partial agonist, reverses delay-induced deficits in the T-maze. | 1998-08 |
|
| The profile of sabcomeline (SB-202026), a functionally selective M1 receptor partial agonist, in the marmoset. | 1998-05 |
|
| Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere. | 1997-12-19 |
|
| SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors. | 1997-12 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47796
Created by
admin on Mon Mar 31 18:01:49 GMT 2025 , Edited by admin on Mon Mar 31 18:01:49 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
A24BK93DRR
Created by
admin on Mon Mar 31 18:01:49 GMT 2025 , Edited by admin on Mon Mar 31 18:01:49 GMT 2025
|
PRIMARY | |||
|
159912-58-0
Created by
admin on Mon Mar 31 18:01:49 GMT 2025 , Edited by admin on Mon Mar 31 18:01:49 GMT 2025
|
PRIMARY | |||
|
9577994
Created by
admin on Mon Mar 31 18:01:49 GMT 2025 , Edited by admin on Mon Mar 31 18:01:49 GMT 2025
|
PRIMARY | |||
|
300000055169
Created by
admin on Mon Mar 31 18:01:49 GMT 2025 , Edited by admin on Mon Mar 31 18:01:49 GMT 2025
|
PRIMARY | |||
|
CHEMBL134641
Created by
admin on Mon Mar 31 18:01:49 GMT 2025 , Edited by admin on Mon Mar 31 18:01:49 GMT 2025
|
PRIMARY | |||
|
m9714
Created by
admin on Mon Mar 31 18:01:49 GMT 2025 , Edited by admin on Mon Mar 31 18:01:49 GMT 2025
|
PRIMARY | Merck Index | ||
|
JJ-70
Created by
admin on Mon Mar 31 18:01:49 GMT 2025 , Edited by admin on Mon Mar 31 18:01:49 GMT 2025
|
PRIMARY | |||
|
C152279
Created by
admin on Mon Mar 31 18:01:49 GMT 2025 , Edited by admin on Mon Mar 31 18:01:49 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD